National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 269222

History of Changes from the VAERS Wayback Machine

First Appeared on 12/30/2006

VAERS ID: 269222
Age:
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2006-12-14
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) / MERCK & CO. INC. - / 0 UN / -

Administered by: Other      Purchased by: Unknown
Symptoms: Injection site oedema

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type':

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unsp"ecified medical attention was sought. At the time of the report, the patient''''s outcome was unknown.


Changed on 12/8/2009

VAERS ID: 269222 Before After
Age:
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2006-12-14
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HUMAN PAPILLOMAVIRUS RECOMBINANT VACCINE, QUADRIVALENT (GARDASIL) HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / -

Administered by: Other      Purchased by: Unknown Other
Symptoms: Injection site oedema

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness:
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK
CDC 'Split Type': (blank) WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unsp"ecified Unspecified medical attention was sought. At the time of the report, the patient''''s patient''s outcome was unknown.


Changed on 1/5/2010

VAERS ID: 269222 Before After
Age:(blank) 21.0
Gender:Female
Location:Pennsylvania
Vaccinated:0000-00-00 2006-11-24
Onset:0000-00-00 2006-11-24
Submitted:2006-12-14 2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU: INFLUENZA (SEASONAL) (FLUZONE 00-01) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - 0961F / 0 UN / - IM

Administered by: Other Private      Purchased by: Other
Symptoms: Injection site oedema

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: UNK None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


Changed on 7/31/2010

VAERS ID: 269222 Before After
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2006-11-24
Onset:2006-11-24
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU: INFLUENZA (SEASONAL) (FLUZONE 00-01) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0961F / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Injection site oedema, Injection site swelling, Immediate post-injection reaction

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


Changed on 8/31/2010

VAERS ID: 269222 Before After
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2006-11-24
Onset:2006-11-24
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU: INFLUENZA (SEASONAL) (FLUZONE 00-01) INFLUENZA (SEASONAL) (FLUZONE) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0961F / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Injection site oedema, Injection site swelling, Immediate post-injection reaction

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


Changed on 7/7/2013

VAERS ID: 269222 Before After
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2006-11-24
Onset:2006-11-24
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU: INFLUENZA (SEASONAL) (FLUZONE) / AVENTIS PASTEUR U2197AA / 5 UN / IM
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0961F / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Injection site oedema, Injection site swelling, Immediate post-injection reaction

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


Changed on 6/14/2014

VAERS ID: 269222 Before After
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2006-11-24
Onset:2006-11-24
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0961F / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Injection site oedema, Injection site swelling, Immediate post-injection reaction

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


Changed on 5/14/2017

VAERS ID: 269222 Before After
Age:21.0
Gender:Female
Location:Pennsylvania
Vaccinated:2006-11-24
Onset:2006-11-24
Submitted:2007-04-06
Entered:2006-12-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / AVENTIS PASTEUR U2197AA / 5 UN / IM
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0961F / 0 UN / IM

Administered by: Private      Purchased by: Other
Symptoms: Injection site oedema, Injection site swelling, Immediate post-injection reaction

Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: UNK
Current Illness: Asthma
Preexisting Conditions: UNK
Diagnostic Lab Data: None
CDC 'Split Type': WAES0611USA07057

Write-up:Information has been received from a nurse concerning a female who was vaccinated with a first dose of HPV vaccine. It was reported that immediately upon administration of the vaccine, the patient developed excessive swelling near the injection site. Unspecified medical attention was sought. At the time of the report, the patient''s outcome was unknown. This is in follow-up to report(s) previously submitted on 12/14/2006. Initial and follow-up information has been received from a nurse and a physician concerning a 21 year old white female student with asthma who on 24-NOV-2006, at 12:00 p.m., was vaccinated IM, into the right arm, with a first dose of GARDASIL (lot #654389/0961F) concomitantly with a sixth dose of FLUZONE (lot #U2197AA) IM, into the left arm. On 24-NOV-2006, at 12:01 p.m., the patient developed immediate swelling at the injection site. The patient recovered on the same day. There were no laboratory or diagnostic tests performed. Additional information is not expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=269222&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166